Is Curaleaf Stock a Buy With Its Attempted Hostile Takeover of Aurora Cannabis Under Way?
7 Articles
7 Articles
Aurora announces UK acquisitions as it urges shareholders to reject Curaleaf takeover
Global investors have started eyeing the UK medical cannabis market as one of Europe's most dynamic growth stories, drawn by its swift rise and promising longer-term prospects. Aurora Cannabis Inc (TSE: ACB) (NASDAQ: ACB) (FRA: 21P) has now made the latest move into this space. On Aug. 19 the Canadian firm acquired Internode Pharma Limited, a licensed importer and wholesaler, and HAP Pharma Limited, a licensed virtual pharmacy based in Birmingha…
Curaleaf - Aurora Hostile Bid Heats Up Further
In the latest Trade To Black podcast presented by Flowhub, hosts Shadd Dales and Anthony Varrell break down the latest twist in the Curaleaf–Aurora hostile takeover fight, plus a hemp email making the rounds that isn’t quite as clean as it sounds, before closing with the weekly Vantage Standard segment on the barriers to international expansion. Aurora Cannabis (TSX: ACB) (NASDAQ: ACB) responded today to Curaleaf’s (TSX: CURA) (OTCQX: CURLF) hos…
Aurora Accuses Curaleaf of 'Pressuring Shareholders' as it Launches Official Takeover Bid
Curaleaf Holdings has pushed ahead with its unexpected and unsolicited acquisition campaign of Aurora Cannabis and has now submitted an official bid for its Canadian rival. The cannabis giant formally launched its takeover bid on August 18, 2026, meaning Aurora’s shareholders must make a decision before the end of the year. Aurora’s board have already responded to the bid, urging shareholders to ‘take no action’ before it has made a formal rec…
Aurora urges no action after Curaleaf's ‘hostile’ takeover bid
Aurora Cannabis has urged shareholders to take no action after Curaleaf Holdings formally launched its “unsolicited” […] The post Aurora urges no action after Curaleaf’s ‘hostile’ takeover bid appeared first on Cannabiz.
Coverage Details
Bias Distribution
- 100% of the sources lean Left
Factuality
To view factuality data please Upgrade to Premium







